Evaluating the Effect of Sage-718 on Cognitive Function in Participants with Huntington’s Disease
Enrolling By Invitation
25 years - 65 years
All
4 participants needed
1 Location
Brief description of study
This is a study that evaluates SAGE-718 in participants with Huntington's Disease.
Detailed description of study
This is a study that evaluates SAGE-718 in participants with Huntington's Disease.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Medical Research, Huntington’s
-
Age: 25 years - 65 years
-
Gender: All
Age 25 to 65 Huntington's Disease
Updated on
04 Aug 2024.
Study ID: 851128
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu
For Cancer trials contact Penn Medicine's Cancer Trial Navigator at: PMCancerResearch@pennmedicine.upenn.edu or 215-349-8245
